IOVA Latest Headlines

How yield surges hit small caps—and why BofA prefers mid caps

at seekingalpha.com (Wed, 7-Oct 12:13 PM)

Iovance Showcases Amtagvi Momentum and Growing TIL Leadership

at www.tipranks.com (Mon, 5-Oct 5:59 PM)

Iovance lifts 2026 revenue outlook by $55 million at the midpoint as Amtagvi and Proleukin demand stays strong

Market Chameleon (Tue, 29-Sep 11:03 AM)

Iovance lifts 2026 revenue outlook by $55 million at the midpoint on strong U.S. demand for Amtagvi and Proleukin

Market Chameleon (Tue, 29-Sep 7:35 AM)

Iovance issues 179,750 inducement options at $10.02 to support new hires

Market Chameleon (Mon, 21-Sep 7:33 AM)

Iovance Awards Inducement Stock Options to New Hires as Pipeline and Commercial Reach Expand

Market Chameleon (Mon, 24-Aug 7:26 AM)

IOVA Delivers Record $99 Million Revenue on Surging Amtagvi Demand and Expanding Global Footprint

Market Chameleon (Thu, 6-Aug 10:30 AM)

Iovance Biotherapeutics Delivers Record $99M Quarterly Revenue and Expands Amtagvi’s Global Footprint Amid Pipeline Advances

Market Chameleon (Thu, 6-Aug 9:07 AM)

Iovance Grants 139,930 Inducement Stock Options to Fuel Cell Therapy Innovation

Market Chameleon (Mon, 20-Jul 8:11 AM)